Metro Manila (CNN Philippines, July 4) — The Department of Science and Technology (DOST) is set to start its government-funded study on convalescent blood plasma as a mode of therapy for COVID-19 patients, Palace said.
Presidential Spokesperson Harry Roque said in a statement Saturday that DOST Secretary Fortunato T. de la Peña has confirmed the new undertaking.
Convalescent plasma is taken from the blood of individuals who have recovered from the coronavirus disease, and is being used as an adjunctive therapy for those who are currently infected by the illness.
“We hope this study will yield positive results and be our country’s contribution to the global effort to develop COVID-19 treatment,” Roque said.
The University of the Philippines-Philippine General Hospital (UP-PGH) will take on the study as it receives funding from the DOST.
